scispace - formally typeset
Search or ask a question
Institution

American Cancer Society

NonprofitAtlanta, Georgia, United States
About: American Cancer Society is a nonprofit organization based out in Atlanta, Georgia, United States. It is known for research contribution in the topics: Cancer & Population. The organization has 1339 authors who have published 3700 publications receiving 688166 citations. The organization is also known as: American Cancer Society, ACS & American Society for the Control of Cancer.


Papers
More filters
Journal ArticleDOI
TL;DR: An understanding of how cancer rehabilitation and palliative care are aligned in goal setting, but distinct in approach may help facilitate earlier integration of both into the oncology care continuum—supporting efforts to improve physical, psychological, cognitive, functional, and quality of life outcomes in patients and survivors.
Abstract: Palliative care and rehabilitation practitioners are important collaborative referral sources for each other who can work together to improve the lives of cancer patients, survivors, and caregivers by improving both quality of care and quality of life. Cancer rehabilitation and palliative care involve the delivery of important but underutilized medical services to oncology patients by interdisciplinary teams. These subspecialties are similar in many respects, including their focus on improving cancer-related symptoms or cancer treatment-related side effects, improving health-related quality of life, lessening caregiver burden, and valuing patient-centered care and shared decision-making. They also aim to improve healthcare efficiencies and minimize costs by means such as reducing hospital lengths of stay and unanticipated readmissions. Although their goals are often aligned, different specialized skills and approaches are used in the delivery of care. For example, while each specialty prioritizes goal-concordant care through identification of patient and family preferences and values, palliative care teams typically focus extensively on using patient and family communication to determine their goals of care, while also tending to comfort issues such as symptom management and spiritual concerns. Rehabilitation clinicians may tend to focus more specifically on functional issues such as identifying and treating deficits in physical, psychological, or cognitive impairments and any resulting disability and negative impact on quality of life. Additionally, although palliative care and rehabilitation practitioners are trained to diagnose and treat medically complex patients, rehabilitation clinicians also treat many patients with a single impairment and a low symptom burden. In these cases, the goal is often cure of the underlying neurologic or musculoskeletal condition. This report defines and describes cancer rehabilitation and palliative care, delineates their respective roles in comprehensive oncology care, and highlights how these services can contribute complementary components of essential quality care. An understanding of how cancer rehabilitation and palliative care are aligned in goal setting, but distinct in approach may help facilitate earlier integration of both into the oncology care continuum-supporting efforts to improve physical, psychological, cognitive, functional, and quality of life outcomes in patients and survivors.

152 citations

Journal ArticleDOI
EE Calle1, CW Heath1, H. L. Miracle-McMahill1, R. J. Coates2  +183 moreInstitutions (39)

152 citations

Journal ArticleDOI
Stefan Nickels1, Thérèse Truong2, Rebecca Hein3, Kristen N. Stevens4, Katharina Buck, Sabine Behrens1, Ursula Eilber1, Martina E. Schmidt1, Lothar Häberle5, Alina Vrieling6, Alina Vrieling1, Mia M. Gaudet7, Jonine D. Figueroa2, Nils Schoof8, Amanda B. Spurdle9, Anja Rudolph1, Peter A. Fasching10, Peter A. Fasching5, John L. Hopper11, Enes Makalic11, Daniel F. Schmidt11, Melissa C. Southey11, Matthias W. Beckmann5, Arif B. Ekici5, Olivia Fletcher, Lorna Gibson12, Isabel dos Santos Silva12, Julian Peto12, Manjeet K. Humphreys13, Jean S Wang13, Emilie Cordina-Duverger2, Florence Menegaux2, Børge G. Nordestgaard14, Stig E. Bojesen14, Charlotte Lanng14, Hoda Anton-Culver15, Argyrios Ziogas15, Leslie Bernstein16, Christina A. Clarke17, Christina A. Clarke18, Hermann Brenner1, Heiko Müller1, Volker Arndt1, Christa Stegmaier, Hiltrud Brauch19, Hiltrud Brauch20, Thomas Brüning21, Volker Harth22, Volker Harth23, Arto Mannermaa24, Vesa Kataja24, Veli-Matti Kosma24, Jaana M. Hartikainen24, Diether Lambrechts, Dominiek Smeets, Patrick Neven25, Robert Paridaens25, Dieter Flesch-Janys22, Nadia Obi22, Shan Wang-Gohrke26, Fergus J. Couch4, Janet E. Olson4, Celine M. Vachon4, Graham G. Giles11, Graham G. Giles27, Gianluca Severi27, Gianluca Severi11, Laura Baglietto27, Laura Baglietto11, Kenneth Offit28, Esther M. John17, Esther M. John18, Alexander Miron29, Irene L. Andrulis30, Julia A. Knight30, Gord Glendon30, Anna Marie Mulligan30, Stephen J. Chanock2, Jolanta Lissowska31, Jianjun Liu32, Angela Cox33, Helen Cramp33, Dan Connley33, Sabapathy P. Balasubramanian33, Alison M. Dunning13, Mitul Shah13, Amy Trentham-Dietz34, Polly A. Newcomb34, Polly A. Newcomb35, Linda J. Titus36, Kathleen Egan37, Elizabeth K. Cahoon2, Preetha Rajaraman2, Alice J. Sigurdson2, Michele M. Doody2, Pascal Guénel2, Paul D.P. Pharoah13, Marjanka K. Schmidt38, Per Hall2, Doug Easton13, Montserrat Garcia-Closas, Roger L. Milne39, Jenny Chang-Claude1, H. B. Christina Justenhoven19, Yon-Dschun Ko, Christian Baisch, Hans-Peter Fischer40, Ute Hamann1, B. Pesch23, Sylvia Rabstein23, Anne Lotz23, Eija Myöhänen41, Helena Kemiläinen41, Heather Thorne41, Eveline Niedermayr41, David D.L. Bowtell41, David D.L. Bowtell9, Georgia Chenevix-Trench9, Georgia Chenevix-Trench41, Anna deFazio41, Anna deFazio9, Dorota M. Gertig9, Dorota M. Gertig41, A. Green9, A. Green41, Penny Webb41, Penny Webb9 
TL;DR: Evidence is provided that the risk of breast cancer associated with some common genetic variants may vary with environmental risk factors, as well as potential interactions between LSP1-rs3817198 and parity and CASP8 and alcohol consumption.
Abstract: Various common genetic susceptibility loci have been identified for breast cancer; however, it is unclear how they combine with lifestyle/environmental risk factors to influence risk. We undertook an international collaborative study to assess gene-environment interaction for risk of breast cancer. Data from 24 studies of the Breast Cancer Association Consortium were pooled. Using up to 34,793 invasive breast cancers and 41,099 controls, we examined whether the relative risks associated with 23 single nucleotide polymorphisms were modified by 10 established environmental risk factors (age at menarche, parity, breastfeeding, body mass index, height, oral contraceptive use, menopausal hormone therapy use, alcohol consumption, cigarette smoking, physical activity) in women of European ancestry. We used logistic regression models stratified by study and adjusted for age and performed likelihood ratio tests to assess gene-environment interactions. All statistical tests were two-sided. We replicated previously reported potential interactions between LSP1-rs3817198 and parity (P-interaction = 2.4 x 10(-6)) and between CASP8-rs17468277 and alcohol consumption (P-interaction = 3.1 x 10(-4)). Overall, the perallele odds ratio (95% confidence interval) for LSP1-rs3817198 was 1.08 (1.01-1.16) in nulliparous women and ranged from 1.03 (0.96-1.10) in parous women with one birth to 1.26 (1.16-1.37) in women with at least four births. For CASP8-rs17468277, the per-allele OR was 0.91 (0.85-0.98) in those with an alcohol intake of = 20 g/day. Additionally, interaction was found between 1p11.2-rs11249433 and ever being parous (P-interaction = 5.3 x 10(-5)), with a per-allele OR of 1.14 (1.11-1.17) in parous women and 0.98 (0.92-1.05) in nulliparous women. These data provide first strong evidence that the risk of breast cancer associated with some common genetic variants may vary with environmental risk factors.

152 citations

Journal ArticleDOI
TL;DR: It is suggested that vitamin E supplementation could have a role in ALS prevention and regular use of vitamin E supplements was associated with a lower risk of dying of ALS.
Abstract: Oxidative stress may contribute to the pathogenesis of amyotrophic lateral sclerosis (ALS). We therefore examined prospectively whether individuals who regularly use supplements of the antioxidant vitamins E and C have a lower risk of ALS than nonusers. The study population comprised 957,740 individuals 30 years of age or older participating in the American Cancer Society's Cancer Prevention Study II. Information on vitamin use was collected at time of recruitment in 1982; participants then were followed up for ALS deaths from 1989 through 1998 via linkage with the National Death Index. During the follow-up, we documented 525 deaths from ALS. Regular use of vitamin E supplements was associated with a lower risk of dying of ALS. The age- and smoking-adjusted relative risk was 0.99 (95% confidence interval [CI], 0.69-1.41) among occasional users, 0.59 (95% CI, 0.36-0.96) in regular users for less than 10 years, and 0.38 (95% CI, 0.16-0.92) in regular users for 10 years or more as compared with nonusers of vitamin E (p for trend = 0.004). In contrast, no significant associations were found for use of vitamin C or multivitamins. These results suggest that vitamin E supplementation could have a role in ALS prevention.

152 citations

Journal ArticleDOI
TL;DR: M mammographic classification seemed to reliably predict good and bad long-term outcomes for survival in tumours of 14 mm or smaller, and especially for those smaller than 10 mm.

152 citations


Authors

Showing all 1345 results

NameH-indexPapersCitations
Walter C. Willett3342399413322
Meir J. Stampfer2771414283776
Frank B. Hu2501675253464
David J. Hunter2131836207050
Edward Giovannucci2061671179875
Irving L. Weissman2011141172504
Bernard Rosner1901162147661
Susan E. Hankinson15178988297
Paolo Boffetta148145593876
Jeffrey A. Bluestone14351577080
Richard D. Smith140118079758
Garth D. Illingworth13750561793
Brian E. Henderson13771269921
Ahmedin Jemal132500380474
Michael J. Thun12939279051
Network Information
Related Institutions (5)
University of Texas MD Anderson Cancer Center
92.5K papers, 4.7M citations

89% related

Memorial Sloan Kettering Cancer Center
65.3K papers, 4.4M citations

89% related

Fred Hutchinson Cancer Research Center
30.9K papers, 2.2M citations

88% related

Mayo Clinic
169.5K papers, 8.1M citations

86% related

University of California, San Francisco
186.2K papers, 12M citations

85% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
202312
20228
2021202
2020239
2019222
2018194